Thyrocare Q3 Profit Jumps 37%, EBITDA Surges 47% Driven by Diagnostics

• Thyrocare Technologies reported a 36.7% YoY increase in net profit to ₹26.1 crore for Q3.
• Revenue from operations grew 19.3% YoY to ₹182 crore, up from ₹152.5 crore a year ago.
• EBITDA surged 46.7% YoY to ₹58.3 crore, with the EBITDA margin expanding to 32% from 26%.
• Diagnostic Testing Services, the largest segment, saw revenue of ₹182.4 crore and drove margin expansion.
• The Imaging Services segment reported stable revenue but continued to post a marginal loss.

Why It Matters: Thyrocare's Q3 performance shows significant profit and EBITDA growth, primarily fueled by its diagnostics segment.